Isometric Preoperative Exercise on Autologous Arteriovenous Fistulas. Randomized Clinical Trial
PHYSICALFAV
Effect of Isometric Preoperative Exercise on Vascular Caliber and the Maturation of Autologous Arteriovenous Fistulas. Randomized Clinical Trial
1 other identifier
interventional
138
1 country
1
Brief Summary
A good vascular access (VA) is vital for hemodialysis (HD) patients. The start of HD with autologous arteriovenous fistula (AVF) means higher survival, lower sanitary costs and complications. The distal forearm AVF is known as the best option but not all patients are good candidates for this surgery, and there is a primary failure rate between 20 and 50% published in literature. The choice of the optimal AVF for each patient is conditioned mainly by the anatomical and hemodynamic characteristics of the artery and the vein chosen to perform the anastomosis. These characteristics can be modified by performing physical exercise Some vascular access guidelines suggest the performance of isometric exercises in the pre and postoperative period of the AVF confection. However, there is very little data in literature on the possible efficacy of preoperative exercise, although small published observational studies point to an improvement in the venous and arterial caliber. Regarding the postoperative exercises, they do seem to improve maturation, however the degree of evidence in literature is low and there is no consensus on the exercise protocol to follow. We present an open-label, multicenter, prospective, controlled and randomized study in order to evaluate the usefulness of preoperative isometric exercise (PIE) in pre-dialysis patients or in prevalent HD with indication of performing a new AVF. The randomization will be 1: 1, one group of patients will perform PIE for 8 weeks and the other group of patients will be a control group. The main purpose will be to evaluate if there is a lower rate of primary failure in the PIE group compared with control group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 29, 2017
CompletedFirst Posted
Study publicly available on registry
July 11, 2017
CompletedStudy Start
First participant enrolled
July 18, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2019
CompletedMarch 6, 2020
March 1, 2020
2 years
June 29, 2017
March 5, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Impact of PIE on AVF primary failure comparing the control group and the PIE group.
We will evaluate in both groups the primary failure rate. It will be evaluated during visit 6 (12 weeks after AVF creation). We expect a lower primary failure rate in the PIE group.
12 weeks after AVF surgery (visit 6)
Secondary Outcomes (5)
Percentage of candidate patients for autologous distal or proximal AVF in both groups.
1 week after AVF surgery (visit 4)
Differences on the caliber of upper arm arteries and veins in the PIE group before and after isometric exercise.
8 weeks follow up visit before surgery (visit 3)
Impact of AVF evaluation with doppler ultrasound in the postoperative period in both groups, adding the usual isometric exercise with ball contraction in all patients.
12 weeks after AVF surgery (visit 6)
Analysis of the optimal arterial and venous calibres to minimize the primary failure of AVF according to the individual risk factors in both groups of patients.
12 weeks after AVF surgery (visit 6)
Impact of nutritional-inflammatory status on AVF outcomes
12 weeks after AVF surgery (visit 6)
Study Arms (2)
Preoperative isometric exercise (PIE) group
EXPERIMENTALIn the PIE group, the patients will perform daily preoperative exercise protocol based on isometric exercises using hand grip and elastic bands. They will perform this protocol for at least six and ideally eight weeks before surgery.
Control group
NO INTERVENTIONControl group patients will follow the usual surgical waiting list protocol (Estimated 1,5-2 months).
Interventions
* Isometric exercises using hand-grip. This exercise consists of two sets of 30 hand-grip contractions with the hand of the upper arm candidate for AVF (in case of doubts about the most appropriate arm for AVF the exercise will be performed with both arms). The patient will rest one minute every 10 contractions and 5 minutes between both sets. The patient will repeat this protocol twice a day, morning and night (Approximately 15 minutes each session). The contraction intensity will start with half of the maximum force obtained by dynamometry and will be increased or decreased to be placed on an effort intensity 2-3 in the Borg scale. * Isometric exercise using elastic bands. At noon the patient will perform a slow contraction session using elastic band with 20 slow repetitions with the arm in flexion and 20 repetitions with the arm in extension. (Total duration: less than 10 minutes)
Eligibility Criteria
You may qualify if:
- Informed consent signature.
- Age between 18 and 89 years.
- Patients with advanced chronic kidney disease, stages IV-V, in pre-dialysis or prevalent HD patients, requiring new AVF.
You may not qualify if:
- Absence of adequate arteries and veins to allow autologous AVF. (The minimum gauges that will be considered in order to perform an autologous AVF are: artery caliber equal or greater than 1.6 mm and vein caliber equal or greater than 1,8 mm with a compressor).
- Diagnosis of coagulopathy or hemoglobinopathy of any cause.
- Patients who urgently need an AVF without the possibility of being 8 weeks on the surgical waiting list.
- Impossibility to perform the physical exercise protocol due to physical or mental disabilities or lack of social support.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Gregorio Marañon
Madrid, 28007, Spain
Related Publications (1)
Nantakool S, Reanpang T, Prasannarong M, Pongtam S, Rerkasem K. Upper limb exercise for arteriovenous fistula maturation in people requiring permanent haemodialysis access. Cochrane Database Syst Rev. 2022 Oct 3;10(10):CD013327. doi: 10.1002/14651858.CD013327.pub2.
PMID: 36184076DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
INES ARAGONCILLO, MD
GREGORIO MARAÑON HOSPITAL
- STUDY CHAIR
ALMUDENA VEGA, MD PHD
GREGORIO MARAÑON HOSPITAL
- STUDY CHAIR
SORAYA ABAD, MD
GREGORIO MARAÑON HOSPITAL
- STUDY CHAIR
NICOLAS MACIAS, MD
GREGORIO MARAÑON HOSPITAL
- STUDY CHAIR
JOSE MANUEL LIGERO, MD
GREGORIO MARAÑON HOSPITAL
- STUDY CHAIR
ROSARIO GARCIA PAJARES, MD
GREGORIO MARAÑON HOSPITAL
- STUDY CHAIR
ANGEL LUIS MORALES, MD
GREGORIO MARAÑON HOSPITAL
- STUDY CHAIR
TERESA CERVERA, MD
GREGORIO MARAÑON HOSPITAL
- STUDY CHAIR
JAVIER RIO, MD
GREGORIO MARAÑON HOSPITAL
- STUDY CHAIR
DIEGO RUIZ CHIRIBOGA, MD
GREGORIO MARAÑON HOSPITAL
- STUDY CHAIR
ELENA MENENDEZ, MD
GREGORIO MARAÑON HOSPITAL
- STUDY CHAIR
MARTA ALBALATE, MD PHD
HOSPITAL INFANTA LEONOR
- STUDY CHAIR
JARA AMPUERO, MD
HOSPITAL DEL SURESTE
- STUDY CHAIR
COVADONGA HEVIA, MD
Hospital Infanta Sofia
- STUDY CHAIR
SILVIA CALDES, MD
Hospital Infanta Sofia
- STUDY CHAIR
YESIKA AMEZQUITA, MD
Hospital Infanta Sofia
- STUDY CHAIR
YOLANDA HERNANDEZ, MD
Hospital Infanta Sofia
- STUDY CHAIR
CRISTINA MORATILLA, MD PHD
CLINICA FUENSANTA
- STUDY CHAIR
CARMEN CABRE, MD
CLINICA FUENSANTA
- STUDY CHAIR
JOSE LUIS MARTIN CONTY
CASTILLA LA MANCHA UNIVERSITY
- STUDY CHAIR
CRISTINA FERNANDEZ, MD PHD
Hospital Clinico de Madrid
- STUDY CHAIR
ISRAEL LEBLIC, MD
Hospital Universitario La Paz
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Nephrologist
Study Record Dates
First Submitted
June 29, 2017
First Posted
July 11, 2017
Study Start
July 18, 2017
Primary Completion
July 31, 2019
Study Completion
October 30, 2019
Last Updated
March 6, 2020
Record last verified: 2020-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- Primary and secondary outcome results will be included in the web site with in 12 month from the end of the study
- Access Criteria
- Public access
Primary and secondary outcome results will be included in the web site with in 12 month from the end of the study